Sanofi to acquire Dynavax for $2.2B to scale adult vaccine portfolio
Sanofi (NASDAQ:SNY) has reached a definitive agreement to acquire vaccine specialist Dynavax Technologies (NASDAQ:DVAX) for $15.50 per share in cash, the companies announced Wednesday.

-640x358.jpg&w=3840&q=75)

-640x358.jpg&w=3840&q=75)
-640x358.jpg&w=3840&q=75)
-640x358.jpg&w=3840&q=75)

-640x358.jpg&w=3840&q=75)

-640x358.jpg&w=3840&q=75)
-640x358.jpg&w=3840&q=75)
